Hypoglycemia revisited in the acute care setting

Yonsei Medical Journal

Volumn 52, Issue 6, 2011, Pages 898-908

  Tsai, Shih Hung ^a   Lin, Yen Yue ^a   Hsu, Chin Wang ^b   Cheng, Chien Sheng ^a   Chu, Der Ming ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Anti diabetic agents; Diabetes mellitus; Emergency medicine; Hyperglycemia; Hypoglycemia; Insulin; Intensive care unit

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DISOPYRAMIDE; FLUCONAZOLE; GATIFLOXACIN; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LEVOFLOXACIN; METFORMIN; PENTAMIDINE; QUININE; QUINOLONE DERIVATIVE; REPAGLINIDE; SEDATIVE AGENT; SIBUTRAMINE; TRIMETHOPRIM;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; ADVERSE OUTCOME; ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; ELECTROLYTE DISTURBANCE; EMERGENCY CARE; FATTY LIVER; FUNCTIONAL DISEASE; GLYCEMIC CONTROL; HEALTH EDUCATION; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOGLYCEMIA ASSOCIATED AUTONOMIC FAILURE; INCIDENCE; INTENSIVE CARE; LUNG EDEMA; PNEUMONIA; QT PROLONGATION; RISK FACTOR; SUDDEN DEATH; TAKOTSUBO CARDIOMYOPATHY;

DIABETES MELLITUS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 80054966006     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.6.898     Document Type: Article

References (123)

1. Kotsaftis P, Ntaios G, Savopoulos C, Kiparoglou R, Agapakis D, Baltatzi M, et al. Trend in incidence of cardiovascular risk factors in elderly and over-aged stroke patients between 2003 and 2007 in Greece. Arch Gerontol Geriatr 2010;50:e31-5.
2. Yu PC, Bosnyak Z, Ceriello A. The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. Diabetes Res Clin Pract 2010;89:1-9.
3. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
4. Egger M, Davey Smith G, Stettler C, Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997;14:919-28.
5. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005;54:3592-601.
6. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001;161:1653-9.
7. Mitchell E, Medzon R. Introduction to emergency medicine. Philadelphia: Lippincott Williams & Willkins; 2005.
8. Tintinalli JE, Stapczynski JS. Tintinalli's emergency medicine: a comprehensive study guide. 7th ed. New York: McGraw-Hill; 2011.
9. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001;161:1653-9.
10. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-76.
11. Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med 2008;358:2630-3.
12. Arabi YM, Tamim HM, Rishu AH. Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med 2009;37:2536-44.
13. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest 2010;137:544-51.
14. Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 2009;301:1556-64.
15. Goyal A, Mehta SR, Díaz R, Gerstein HC, Afzal R, Xavier D, et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation 2009;120:2429-37.
16. Ntaios G, Egli M, Faouzi M, Michel P. J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke 2010;41:2366-70.
17. Mannucci E, Monami M, Mannucci M, Chiasserini V, Nicoletti P, Gabbani L, et al. Incidence and prognostic significance of hypoglycemia in hospitalized non-diabetic elderly patients. Aging Clin Exp Res 2006;18:446-51.
18. Kagansky N, Levy S, Rimon E, Cojocaru L, Fridman A, Ozer Z, et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med 2003;163:1825-9.
19. Wei M, Gibbons LW, Mitchell TL, Kampert JB, Stern MP, Blair SN. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 2000;101:2047-52.
20. Guettier JM, Gorden P. Hypoglycemia. Endocrinol Metab Clin North Am 2006;35:753-66, viii-ix.
21. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245-9.
22. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410-8.
23. Ichai C, Preiser JC; Société Française d'Anesthésie-Réanimation; Société de Réanimation de langue Française; Experts group. International recommendations for glucose control in adult non diabetic critically ill patients. Crit Care 2010;14:R166.
24. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-12.
25. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009;94:709-28.
26. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004;350:2272-9.
27. Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med 2006;23:750-6.
28. Akram K, Pedersen-Bjergaard U, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey. J Diabetes Complications 2006;20:402-8.
29. Control Group, Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52:2288-98.
30. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
31. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
32. Warren RE, Frier BM. Hypoglycaemia and cognitive function. Diabetes Obes Metab 2005;7:493-503.
33. Cryer PE. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endocrinol Metab Clin North Am 1999;28:495-500, v-vi.
34. Thomson FJ, Masson EA, Leeming JT, Boulton AJ. Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients. Age Ageing 1991;20:404-6.
35. Bell DS. Nocturnal hypoglycaemia presenting as somnambulism. Diabetologia 2010;53:2066-7.
36. Redelmeier DA, Kenshole AB, Ray JG. Motor vehicle crashes in diabetic patients with tight glycemic control: a population-based case control analysis. PLoS Med 2009;6:e1000192.
37. Lin YY, Hsu CW, Sheu WH, Chu SJ, Wu CP, Tsai SH. Risk factors for recurrent hypoglycemia in hospitalized diabetic patients admitted for severe hypoglycemia. Yonsei Med J 2010;51:367-74.
38. MacDonald MJ. Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care 1987;10:584-8.
39. Tsalikian E, Mauras N, Beck RW, Tamborlane WV, Janz KF, Chase HP, et al. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr 2005;147:528-34.
40. Huang Z, Sjöholm A. Ethanol acutely stimulates islet blood flow, amplifies insulin secretion, and induces hypoglycemia via nitric oxide and vagally mediated mechanisms. Endocrinology 2008; 149:232-6.
41. Sorlini M, Benini F, Cravarezza P, Romanelli G. Hypoglycemia, an atypical early sign of hepatocellular carcinoma. J Gastrointest Cancer 2010;41:209-11.
42. Lau CI, Wang HC, Hsu WC. Hypoglycemic encephalopathy as the initial presentation of hepatic tumor: a case report. Neurologist 2010;16:206-7.
43. Keller BC, Nussensveig D, Dowell JE. Diffuse large B-cell lymphoma in a hepatitis C virus-infected patient presenting with lactic acidosis and hypoglycemia. Am J Med Sci 2010;339:202-4.
44. Diaz J, Antoine J, Azad N. A case of hypoglycemia, lactic acidosis, and hematologic malignancy. Endocr Pract 2010;16:241-3.
45. Home PD, Fritsche A, Schinzel S, Massi-Benedetti M. Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine. Diabetes Obes Metab 2010;12:772-9.
46. Hamnvik OP, McMahon GT. Balancing risk and benefit with oral hypoglycemic drugs. Mt Sinai J Med 2009;76:234-43.
47. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
48. Harrower AD. Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency. Clin Pharmacokinet 1996;31:111-9.
49. Campbell RK. Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus. Ann Pharmacother 1998;32: 1044-52.
50. Holstein A, Plaschke A, Hammer C, Egberts EH. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia. Eur J Clin Pharmacol 2003;59:91-7.
51. Neumiller JJ, Setter SM, Gates BJ, Sonnett TE, Dobbins EK, Campbell K. Pharmacological management of glycemic control in the geriatric patient with type 2 diabetes mellitus. Consult Pharm 2009;24:45-63.
52. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997;157:1681-6.
53. Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf 2010;9:675-81.
54. Barnett AH. Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy. Curr Med Res Opin 2010;26:1333-42.
55. Holstein A, Egberts EH. Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes. Exp Clin Endocrinol Diabetes 2003;111:405-14.
56. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006;355:2427-43.
57. Hamann A, Garcia-Puig J, Paul G, Donaldson J, Stewart M. Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone. Exp Clin Endocrinol Diabetes 2008;116:6-13.
58. Barnett AH, Cradock S, Fisher M, Hall G, Hughes E, Middleton A. Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Int J Clin Pract 2010; 64:1121-9.
59. Raptis SA, Dimitriadis GD. Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers. Exp Clin Endocrinol Diabetes 2001;109 Suppl 2:S265-87.
60. Murad MH, Coto-Yglesias F, Wang AT, Sheidaee N, Mullan RJ, Elamin MB, et al. Clinical review: Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 2009;94:741-5.
61. Kelesidis T, Canseco E. Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect. Am J Med 2010;123:e5-6.
62. Kelesidis T, Canseco E. Levofloxacin-induced hypoglycemia: a rare but life-threatening side effect of a widely used antibiotic. Am J Med 2009;122:e3-4.
63. Soldevila Madorell B, Joaquim Ortiz C, Colomé Tatché E, Flores Meneses L. [Tonic water as cause of severe hypoglycemia in non-diabetic subject]. Med Clin (Barc) 2006;127:639.
64. Negishi M, Shimomura K, Proks P, Mori M, Shimomura Y. Mechanism of disopyramide-induced hypoglycaemia in a patient with Type 2 diabetes. Diabet Med 2009;26:76-8.
65. Saraya A, Yokokura M, Gonoi T, Seino S. Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels. Eur J Pharmacol 2004;497:111-7.
66. Maeda N, Tamagawa T, Niki I, Miura H, Ozawa K, Watanabe G, et al. Increase in insulin release from rat pancreatic islets by quinolone antibiotics. Br J Pharmacol 1996;117:372-6.
67. Schelleman H, Bilker WB, Brensinger CM, Wan F, Hennessy S. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide. Clin Pharmacol Ther 2010;88:214-22.
68. Roustit M, Blondel E, Villier C, Fonrose X, Mallaret MP. Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient. Ann Pharmacother 2010;44:764-7.
69. Lin YY, Hsu CW, Chu SJ, Tsai SH. Another dangerous combination for hypoglycemic coma: concurrent use of sibutramine and lorazepam. QJM 2008;101:243-5.
70. Hatzitolios A, Savopoulos C, Ntaios G, Papadidaskalou F, Dimitrakoudi E, Kosmidou M, et al. Stroke and conditions that mimic it: a protocol secures a safe early recognition. Hippokratia 2008;12:98-102.
71. Adams H, Adams R, Del Zoppo G, Goldstein LB; Stroke Council of the American Heart Association; American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36:916-23.
72. ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005;112:IV1-203.
73. Whiticar R, Smith S, Wathen C. Hypoglycaemia--one of the 'H's or not! Resuscitation 2007;74:573-4.
74. Tintinalli JE, Kelen GD, Stapczynski JS. Emergency medicine: a comprehensive study guide. 6th ed. New York: McGraw-Hill, Medical Pub. Division; 2004.
75. Sinert R, Su M, Secko M, Zehtabchi S. The utility of routine laboratory testing in hypoglycaemic emergency department patients. Emerg Med J 2009;26:28-31.
76. Socransky SJ, Pirrallo RG, Rubin JM. Out-of-hospital treatment of hypoglycemia: refusal of transport and patient outcome. Acad Emerg Med 1998;5:1080-5.
77. Carter AJ, Keane PS, Dreyer JF. Transport refusal by hypoglycemic patients after on-scene intravenous dextrose. Acad Emerg Med 2002;9:855-7.
78. Mechem CC, Kreshak AA, Barger J, Shofer FS. The short-term outcome of hypoglycemic diabetic patients who refuse ambulance transport after out-of-hospital therapy. Acad Emerg Med 1998;5:768-72.
79. Lin YY, Hsu CW, Sheu WH, Chu SJ, Wu CP, Tsai SH. Use of therapeutic responses to glucose replacement to predict glucose patterns in diabetic patients presenting with severe hypoglycaemia. Int J Clin Pract 2009;63:1161-6.
80. Lu M, Inboriboon PC. Lantus insulin overdose: A case report. J Emerg Med 2010.
81. Thewjitcharoen Y, Lekpittaya N, Himathongkam T. Attempted suicide by massive insulin injection: a case report and review of the literature. J Med Assoc Thai 2008;91:1920-4.
82. Boyle PJ, Justice K, Krentz AJ, Nagy RJ, Schade DS. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 1993;76: 752-6.
83. Lheureux PE, Zahir S, Penaloza A, Gris M. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide. Crit Care 2005;9:543-9.
84. Vallurupalli S. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure. Ann Pharmacother 2010;44:387-90.
85. Gonzalez RR, Zweig S, Rao J, Block R, Greene LW. Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure. Endocr Pract 2007;13:417-23.
86. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009;37:3001-9.
87. Gogitidze Joy N, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, Davis SN. Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 2010;33:1529-35.
88. Infusino F, Pitocco D, Zaccardi F, Scalone G, Coviello I, Nerla R, et al. Low glucose blood levels are associated with abnormal cardiac sympatho-vagal balance in type 2 diabetic patients with coronary artery disease. Eur Rev Med Pharmacol Sci 2010;14:203-7.
89. Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited. Diabetologia 2009;52:42-5.
90. Feldman-Billard S, Massin P, Meas T, Guillausseau PJ, Héron E. Hypoglycemia-induced blood pressure elevation in patients with diabetes. Arch Intern Med 2010;170:829-31.
91. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360: 1903-13.
92. Ohwada R, Hotta M, Kimura H, Takagi S, Matsuda N, Nomura K, et al. Ampulla cardiomyopathy after hypoglycemia in three young female patients with anorexia nervosa. Intern Med 2005; 44:228-33.
93. Ono T, Kasaoka S, Fujita M, Yamashita S, Kumagai K, Kaneda K, et al. Complete recovery from severe myocardial dysfunction in a patient with anorexia nervosa. J Cardiol 2009;54:480-4.
94. Bergner DW, Goldberger JJ. Diabetes mellitus and sudden cardiac death: what are the data? Cardiol J 2010;17:117-29.
95. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999;16:466-71.
96. Gamble JM, Eurich DT, Marrie TJ, Majumdar SR. Admission hypoglycemia and increased mortality in patients hospitalized with pneumonia. Am J Med 2010;123:556.e11-6.
97. Singanayagam A, Chalmers JD, Hill AT. Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia. Eur Respir J 2009;34:932-9.
98. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, et al. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010;85:217-24.
99. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
100. Margulescu AD, Sisu RC, Cinteza M, Vinereanu D. Noncardiogenic acute pulmonary edema due to severe hypoglycemia--an old but ignored cause. Am J Emerg Med 2008;26:839.e3-6.
101. Mishriki YY. Hypoglycemia-induced neurogenic-type pulmonary edema: an underrecognized association. Endocr Pract 2004;10: 429-31.
102. Uchida D, Ohigashi S, Hikita S, Kitamura N, Motoyoshi M, Tatsuno I. Acute pulmonary edema caused by hypoglycemia due to insulin overdose. Intern Med 2004;43:1056-9.
103. Sontineni SP, Lee JM, Porter J. Hypoglycemia-induced pontine infarction in a diabetic male with basilar artery stenosis: insight into the mechanisms of hypoglycemic stroke. Cerebrovasc Dis 2008;25:281-2.
104. Shirayama H, Ohshiro Y, Kinjo Y, Taira S, Teruya I, Nakachi K, et al. Acute brain injury in hypoglycaemia-induced hemiplegia. Diabet Med 2004;21:623-4.
105. Jarjour IT, Ryan CM, Becker DJ. Regional cerebral blood flow during hypoglycaemia in children with IDDM. Diabetologia 1995;38:1090-5.
106. Kim JH, Roh JH, Koh SB. Reversible injury of internal capsule and splenium in a patient with transient hypoglycemic hemiparesis. Cerebrovasc Dis 2006;22:282-3.
107. Ma JH, Kim YJ, Yoo WJ, Ihn YK, Kim JY, Song HH, et al. MR imaging of hypoglycemic encephalopathy: lesion distribution and prognosis prediction by diffusion-weighted imaging. Neuroradiology 2009;51:641-9.
108. Auer RN. Hypoglycemic brain damage. Metab Brain Dis 2004;19:169-75.
109. Purucker E, Nguyen HN, Lammert F, Koch A, Matern S. Central pontine myelinolysis and myocardial infarction following severe hypoglycemia. Intensive Care Med 2000;26:1406-7.
110. de Courten-Myers GM, Xi G, Hwang JH, Dunn RS, Mills AS, Holland SK, et al. Hypoglycemic brain injury: potentiation from respiratory depression and injury aggravation from hyperglyce mic treatment overshoots. J Cereb Blood Flow Metab 2000;20: 82-92.
111. Michel P, Odier C, Rutgers M, Reichhart M, Maeder P, Meuli R, et al. The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke 2010;41:2491-8.
112. Schopman JE, Geddes J, Frier BM. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. betes Res Clin Pract 2010;87:64-8.
113. Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med 2008;25:501-4.
114. Izumi K, Kondo S, Okada T. A case of atypical thyroid storm with hypoglycemia and lactic acidosis. Endocr J 2009;56:747-52.
115. Homma M, Shimizu S, Ogata M, Yamada Y, Saito T, Yamamoto T. Hypoglycemic coma masquerading thyrotoxic storm. Intern Med 1999;38:871-4.
116. Moghetti P, Castello R, Tosi F, Zenti MG, Magnani C, Bolner A. Glucose counterregulatory response to acute hypoglycemia in hyperthyroid human subjects. J Clin Endocrinol Metab 1994 78:169-73.
117. Nishizawa S, Nakamura T, Hamaoka T, Matsumuro A, Sawada T, Matsubara H. Lethal arrhythmia and corticosteroid insufficiency. Am J Emerg Med 2009;27:1167.e1-3.
118. Heller SR, Robinson RT. Hypoglycaemia and associated hypokalaemia in diabetes: mechanisms, clinical implications and prevention. Diabetes 2000;2:75-82.
119. Paolisso G, Sgambato S, Passariello N, Giugliano D, Scheen A, D'Onofrio F, et al. Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia 1986;29:644-7.
120. Tofade TS, Liles EA. Intentional overdose with insulin glargine and insulin aspart. Pharmacotherapy 2004;24:1412-8.
121. Matsumura M, Nakashima A, Tofuku Y. Electrolyte disorders following massive insulin overdose in a patient with type 2 diabetes. Intern Med 2000;39:55-7.
122. Jolliet P, Leverve X, Pichard C. Acute hepatic steatosis complicating massive insulin overdose and excessive glucose administration. Intensive Care M 2001;27:313-6.
123. Tsujimoto T, Takano M, Nishiofuku M, Yoshiji H, Matsumura Y, Kuriyama S, et al.Rapid onset of glycogen storage hepatomegaly in a type-2 diabetic patient after a massive dose of long-acting insulin and large doses of glucose. Intern Med 2006;45:469-73.